Technology
3D Printing Medical Devices Market size is set to grow by USD 7.07 billion from 2024-2028, Increased demand for personalized or customized medical devices boost the market, Technavio
Published
2 years agoon
By
NEW YORK, July 30, 2024 /PRNewswire/ — The global 3D printing medical devices market size is estimated to grow by USD 7.07 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 25.2% during the forecast period. Increased demand for personalized or customized medical devices is driving market growth, with a trend towards rising focus on the research for the use of 3D printing process to manufacture living organs and cell structures. However, high initial setup cost of 3d printing facility poses a challenge. Key market players include 3D Systems Corp., Anatomics Pty Ltd., Autodesk Inc., Biomerics LLC, Boston Scientific Corp., Desktop Metal Inc., EOS GmbH, Exail Technologies, Formlabs Inc., General Electric Co., INTAMSYS TECHNOLOGY CO. LTD., MATERIALISE NV, Mecuris GmbH, Medtronic Plc, Organovo Holdings Inc., Qualtech Consulting Corp., Renishaw Plc, Schultheiss GmbH, SLM Solutions Group AG, and Stratasys Ltd..
Get a detailed analysis on regions, market segments, customer landscape, and companies- View the snapshot of this report
3D Printing Medical Devices Market Scope
Report Coverage
Details
Base year
2023
Historic period
2018 – 2022
Forecast period
2024-2028
Growth momentum & CAGR
Accelerate at a CAGR of 25.2%
Market growth 2024-2028
USD 7079.6 million
Market structure
Fragmented
YoY growth 2022-2023 (%)
19.78
Regional analysis
North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution
North America at 40%
Key countries
US, Germany, UK, Japan, and China
Key companies profiled
3D Systems Corp., Anatomics Pty Ltd., Autodesk Inc., Biomerics LLC, Boston Scientific Corp., Desktop Metal Inc., EOS GmbH, Exail Technologies, Formlabs Inc., General Electric Co., INTAMSYS TECHNOLOGY CO. LTD., MATERIALISE NV, Mecuris GmbH, Medtronic Plc, Organovo Holdings Inc., Qualtech Consulting Corp., Renishaw Plc, Schultheiss GmbH, SLM Solutions Group AG, and Stratasys Ltd.
Market Driver
The 3D printing of medical devices, specifically in the field of bioprinting, represents a significant advancement in healthcare technology. This process involves the precise layering of cells, biologic scaffolds, and growth factors to create bioidentical tissue, such as stem cells, skin grafts, and bone and cartilage. Unlike traditional 3D printers that use plastic or metals as raw materials, 3D bioprinters utilize a computer-guided pipette to layer living cells, referred to as bioink, to create artificial living tissues. One of the most promising applications of 3D bioprinting is in organ replacement. This technology holds the potential to address the organ donor shortage and reduce rejections by creating organs that better meet the requirements of the body. For instance, 3D printed bone features a micropore surface that allows osteocytes to adhere, join, and heal better than traditional metal implants. ORGANOVO, a biotechnology company, is pioneering the use of 3D bioprinting to develop in vivo liver tissues for treating rare, life-threatening diseases. Their product, the ExVive 3D Bioprinted Human Liver Tissues, can be used for drug exposure and metabolism studies, offering a valuable alternative to organ transplantation. Allevi and SHIBUYA are among the companies leading the way in 3D bioprinting technology. Allevi introduced the first desktop 3D bioprinter capable of printing living tissues using human cells, while SHIBUYA’s 3D bioprinter is the first cell culture system for building complex cell-based structures. The potential of 3D bioprinting is driving increased R&D efforts in developing devices for this technology. As technological advances continue, 3D printing medical devices are expected to see widespread adoption, fueling the growth of the global 3D printing medical devices market.
The 3D Printing Medical Devices market is experiencing significant growth due to its ability to produce customized, patient-specific solutions for various medical applications. Stereolithography (SLA) and digital light processing are popular 3D printing technologies used in creating prosthetics implants, orthopedic implants, and wearable medical devices. Dentistry and orthodontics also benefit from 3D printing, with applications including dentures, bone scaffolds, and hearing aids. Tissue-engineered products, remote patient monitoring, telemedicine, and vital signs monitoring are other areas where 3D printing is making an impact. Complex medical procedures, such as implantable and non-implantable medical devices, drug testing, and organ and tissue production, are also being revolutionized by this technology. Computer-aided manufacturing and design, diagnostic centers, medical institutions, and 3D printing laboratories are embracing 3D printing to provide personalized solutions. Laser beam technology, minimally invasive surgery, and surgical equipment are other areas where 3D printing is making a difference. Patient CAD images are used to create patient-specific models and customized implants, including cranial implants for neurosurgery and human skull repairs. Overall, 3D printing is transforming the medical industry by enabling the production of customized, high-quality medical devices in a layer-wise manner.
Discover 360° analysis of this market. For complete information, schedule your consultation – Book Here!
Market Challenges
The 3D printing medical devices market faces significant challenges due to high capital costs. Equipment for 3D printing or outsourced print service contracts, advanced software for post-processing, and proprietary raw materials contribute to these costs. Desktop FDM or SLA machines cost less than USD5,000, but high-end additive manufacturing printers range from USD200,000 to USD850,000 or even millions. Skilled personnel and training are also necessary, adding to the expenses. A clinical 3D printing lab requires ancillary staff for printing. Production time, ranging from hours to days, limits its use in mass manufacturing. These factors hinder the widespread adoption of 3D printers, potentially impacting the growth of the market negatively.The 3D printing medical devices market is experiencing significant growth due to the advantages it offers in creating customized solutions for various medical needs. However, there are challenges that need to be addressed. For physicians, the use of 3D-printed medical devices in elective surgical procedures requires careful consideration for complex prosthetic limbs and brain designs. Surgeons prefer titanium alloys for surgical tools, but cancer patients benefit from biocompatible materials as drug contact materials. Hearing aid manufacturers are exploring 3D-printed hearing aid devices using biocompatible materials for personalized solutions. CAD/CAM technology and desktop printers are revolutionizing dental clinics and hospitals, providing dental restoration, surgical planning, and personalized prosthetics. Orthopedic prosthetics and surgical instruments also benefit from 3D printing, improving surgical outcomes, operation time, and reducing post-surgical complications. Mechanical protection for tissues and organs is a promising area for 3D printing, with potential applications in organ transplantation and living cells using biomaterials. However, biosafety concerns and ethical issues surrounding the use of human cells and tissues need to be addressed by regulatory bodies like the Human Tissue Authority. Photopolymerization and Medical device manufacturers are using rapid prototyping to innovate, while healthcare professionals embrace the technology for prosthetics, surgical instruments, personalized prosthetics, orthotics, surgeon comfort, and fatigue prevention.
For more insights on driver and challenges – Request a sample report!
Segment Overview
This 3d printing medical devices market report extensively covers market segmentation by
Application 1.1 Orthopedic and spinal1.2 Dental1.3 Hearing aids1.4 OthersEnd-user 2.1 Hospitals and clinics2.2 Academic institutes2.3 Pharma and biotech companies2.4 OthersGeography 3.1 North America3.2 Europe3.3 Asia3.4 Rest of World (ROW)
1.1 Orthopedic and spinal- The 3D printing medical devices market encompasses the production of orthopedic and spinal implants using 3D printing technology. This technology enables the fabrication of standard-sized implants, patient-matched implants, and custom implants for individuals with deformities. Hospitals and ambulatory surgery centers are major end-users, as 3D printing allows for the creation of complex structures and individualized implants. Orthopedic and spinal applications dominate the market due to the rising prevalence of related disorders, increasing demand for personalized implants, and the need for advanced surfaces and structures. The technology’s ability to manufacture lattice structures and porous surfaces promotes bone ingrowth and improves implant stability. Titanium implants, commonly used in orthopedics, benefit from 3D printing’s ability to create greater porosity, enhancing bony ingrowth and improving implant stability. In the field of prosthetics, 3D printing significantly reduces manufacturing time and costs while maintaining functionality. The technology’s affordability makes it particularly suitable for children who quickly outgrow their prosthetic limbs. Vendors are increasing investments in R&D to develop advanced orthopedic and spinal implants, further fueling market growth. Key factors driving the market include the aging population, increasing prevalence of orthopedic and spinal disorders, and the demand for customized implants. These factors are expected to propel the growth of the global 3D printing medical devices market during the forecast period.
For more information on market segmentation with geographical analysis including forecast (2024-2028) and historic data (2017-2021) – Download a Sample Report
Research Analysis
The 3D printing medical devices market is revolutionizing the healthcare industry by enabling the production of customized medical products in a layer-wise manner using CAD images. This technology allows for the creation of patient-specific products, including implants, hearing aids, bone scaffolds, surgical equipment, and more. The process begins with the creation of patient CAD images, which are then used to manufacture standard implants or personalized prosthetics, surgical instruments, and orthotics. The benefits of 3D printing in medical devices extend beyond patient comfort, as it also allows for the production of implantable and non-implantable medical devices using biomaterials, as well as drug testing and potential applications in organ transplantation and tissue engineering. Rapid prototyping and computer-aided manufacturing are key technologies driving the growth of this market, with healthcare professionals and medical device manufacturers embracing the technology to improve patient outcomes and surgical procedures.
Market Research Overview
The 3D printing medical devices market is revolutionizing the healthcare industry by enabling the production of customized medical products in a layer-wise manner using CAD images. This technology allows for the creation of patient-specific products such as implants, hearing aids, bone scaffolds, surgical equipment, and more. The use of patient CAD images ensures a perfect fit and optimal surgical outcomes, reducing operation time and post-surgical complications. 3D printing technology is being applied in various medical fields, including neurosurgery, orthopedics, and dentistry. For instance, it is used to create cranial implants, patient-specific models, and surgical tools for complex procedures. The use of biocompatible materials, such as titanium alloys and photopolymers, ensures the safety and effectiveness of 3D-printed medical devices. The market for 3D-printed medical devices is vast and diverse, encompassing elective surgical procedures, complex prosthetic limbs, brain designs, surgical instruments, and more. The technology is also being used in tissue engineering and organ transplantation, with the potential to print living cells and biomaterials. However, the use of 3D printing in medicine raises biosafety concerns and ethical issues, particularly with regard to the Human Tissue Authority and patient privacy. Medical device manufacturers are working to address these challenges through the use of CAD/CAM technology, rapid prototyping, and collaboration with healthcare professionals. The market for 3D-printed medical devices includes hearing aid manufacturers, dental clinics, hospitals, and surgical planning centers. The technology is also being used to create implantable and non-implantable medical devices, wearable medical devices, and diagnostic tools. The potential applications of 3D printing in medicine are vast, from surgical planning and dental restoration to remote patient monitoring and telemedicine. The future of medicine is undoubtedly 3D printed.
Table of Contents:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation
ApplicationOrthopedic And SpinalDentalHearing AidsOthersEnd-userHospitals And ClinicsAcademic InstitutesPharma And Biotech CompaniesOthersGeographyNorth AmericaEuropeAsiaRest Of World (ROW)
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
View original content to download multimedia:https://www.prnewswire.com/news-releases/3d-printing-medical-devices-market-size-is-set-to-grow-by-usd-7-07-billion-from-2024-2028–increased-demand-for-personalized-or-customized-medical-devices-boost-the-market-technavio-302209578.html
SOURCE Infiniti Research, Inc.
You may like
Technology
Portland Public Library Delivers Almost 50% Increase In User Engagement with New Web Redesign
Published
15 minutes agoon
April 21, 2026By
MIAMI, April 21, 2026 /PRNewswire/ — Digital Silk, an award-winning agency focused on creating brand strategies, custom websites, and digital marketing campaigns, announces the launch of a redesigned website for Portland Public Library, a public institution serving the education, community services, and nonprofit sector. The project focuses on improving user experience, content discoverability, and engagement while introducing a scalable CMS to support ongoing updates. The new platform is now live at https://www.portlandlibrary.org/.
The redesigned website reflects a strategic effort to better serve a diverse audience by improving navigation, enhancing accessibility, and creating clearer pathways to programs, events, and resources.
Improving Engagement Through User-Centric Design
Portland Public Library required a modern digital platform to address challenges related to fragmented navigation, limited engagement pathways, and difficulty in accessing content. The previous website structure made it harder for users to find relevant information efficiently.
Digital Silk addressed these challenges through a full website redesign supported by user-centric information architecture and optimized user journeys. The updated experience prioritizes clarity, accessibility, and ease of navigation across a wide range of services and resources.
“Organizations like public libraries are increasingly relying on their digital platforms to serve as primary engagement hubs, making usability and content clarity more important than ever,” said Ana Margarida Meira, VP, Client Partner.
Measurable Improvements in User Engagement
Following the launch, Portland Public Library recorded measurable improvements in engagement metrics when comparing Feb 17 to Mar 23, 2026, against the previous period.
Key outcomes include:
+47.82% increase in average engagement time per active user+4.5% increase in engaged sessions per active user+18.38% increase in average engagement time per session
These improvements may indicate stronger interaction with site content and increased user engagement across programs and services.
Key Deliverables Supporting Accessibility and Scalability
The project combined design, UX strategy, and technical development to support both immediate engagement improvements and long-term flexibility.
Core deliverables included:
Full website redesign and developmentUser-centric information architectureEngagement-focused UX design and user journey optimizationInclusive design enhancementsScalable CMS with modular content componentsPerformance optimization and QA testing
The implementation enables the library’s internal team to manage content more efficiently while supporting dynamic updates for seasonal programming and community initiatives.
Supporting a Shift Toward Inclusive Digital Experiences
The project reflects a broader trend among public institutions and content-heavy organizations to prioritize inclusive design, improved content discoverability, and scalable content management systems. Increasingly, organizations are focusing on engagement metrics as a measure of digital effectiveness.
“A well-structured, user-centric website can significantly increase engagement by making it easier for diverse audiences to find, explore, and interact with valuable resources and services,” said Ana Margarida Meira, VP, Client Partner.
Building a Foundation for Ongoing Community Engagement
The redesigned platform provides Portland Public Library with a flexible and scalable foundation to support future growth. By improving accessibility and navigation, the website is positioned to better connect users with educational programs, community services, and digital resources.
More information about Digital Silk’s web development capabilities is available at https://www.digitalsilk.com/ and organizations can request a quote here.
About Digital Silk
Digital Silk is an award-winning Miami Web Development Agency focused on growing brands online. With a team of seasoned experts, Digital Silk creates digital experiences through strategic branding, custom web design, and digital marketing services to help improve visibility and support engagement.
Media Contact
Jessica Erasmus
Marketing Director & PR Manager
Tel: (800) 206-9413
Email: jessica@digitalsilk.com
View original content:https://www.prnewswire.com/news-releases/portland-public-library-delivers-almost-50-increase-in-user-engagement-with-new-web-redesign-302747609.html
SOURCE Digital Silk
Technology
LUMA Vision to Showcase VERAFEYE 4D Imaging Platform at HRS 2026, Signaling a New Foundation for EP Guidance
Published
15 minutes agoon
April 21, 2026By
DUBLIN, April 21, 2026 /PRNewswire/ — LUMA Vision, a leader in real-time 4D cardiac imaging and navigation, today announced its participation in the Heart Rhythm Society Annual Meeting (HRS 2026) in Chicago, where the company will showcase its VERAFEYE™ Visualization and Guidance Platform and highlight new clinical progress through physician-led presentations and scientific sessions.
At HRS 2026, LUMA Vision will demonstrate how VERAFEYE enables direct, real-time visualization of cardiac anatomy, catheters, and therapy delivery—a step-change from conventional imaging and mapping approaches. By combining live 2D and 4D intra-procedural imaging with precise digital anatomical models, the platform delivers CT-quality visualization in seconds, supporting faster, more intuitive, and more precise procedures.
VERAEYE is redefining EP Guidance — from tools to platform, VERAFEYE is designed to eliminate the fragmentation of current EP workflows by enabling physicians to see and guide therapy in real time, rather than relying on the traditional three separate systems of point-by-point mapping, ICE and fluoroscopy. Early clinical experience demonstrates the platform’s ability to:
Enable efficient single-operator workflowsSupport multiple ablation technologiesEliminate the use of fluoroscopyIntroduce a true two-catheter procedure
LUMA Vision will be featured across multiple sessions:
Wednesday, April 22 | 3:00 PM Embassy Suites by Hilton Chicago
Dr. Shephal Doshi will present at the Stanford Biodesign New Arrhythmia Technologies Retreat, highlighting the role of real-time 4D imaging in advancing EP innovation.
Thursday, April 23 | 5:00 PM McCormick Place Convention Center • Room S406AB
Dr. Vivek Reddy will present “AF Ablation with a Large-Focal PFA Catheter & Integrated Guidance” at the 3rd Annual PFA LIVE Case Summit, featuring the VERAFEYE™ System in collaboration with CardioFocus.
Saturday, April 25 | Time 12:00 to 2:00 PM Abstract Pavilion, McCormick Place (Exhibit Hall)
Dr. Toni Breskovic will present new clinical data demonstrating real-world workflow validation and procedural impact.
“This is a defining moment not only for LUMA Vision, but for the future architecture of cardiac procedures. VERAFEYE is a globally unique, AI–powered system that sits at the intersection of electrophysiology, left atrial appendage closure, and structural heart interventions, designed as a unified operating layer rather than a standalone procedural tool,” said Fionn Lahart, CEO of LUMA Vision. “What we are introducing with VERAFEYE is a unified, real–time view of the heart that has the potential to become the foundation for how cardiac procedures are performed. As the field advances toward next–generation ablation technologies, guidance will no longer be an accessory. It will be the AI–enabled decision–making platform on which everything else is built.”
Driven by advanced AI algorithms, VERAFEYE interprets cardiac anatomy in real time, creating a single anatomical and guidance framework that spans multiple procedures. This intelligent foundation establishes a common procedural language through which therapies can enable greater precision, more efficient workflows, and tighter integration across the cardiac ecosystem.
Throughout the week, attendees are invited to visit Booth #2415 to meet the clinical team and experience how VERAFEYE delivers CT-quality digital anatomy in seconds, enabling a new level of precision and control in EP procedures. As EP continues to evolve toward energy-agnostic, platform-driven workflows, VERAFEYE is positioned to serve as a foundational imaging layer integrating across mapping systems.
About LUMA Vision
LUMA Vision is a privately held medical technology company headquartered in Dublin, Ireland, with key operations in Munich, Germany. The company designs and develops next-generation cardiac visualization and navigation systems that empower clinicians to see and treat with unmatched precision. VERAFEYE™, LUMA Vision’s flagship platform, delivers a real-time, 360° intracardiac view with an unprecedented field of visualization, redefining procedural accuracy in electrophysiology and structural heart interventions. Founded by CEO Fionn Lahart and CTO Christoph Hennersperger, LUMA Vision is committed to transforming cardiac care through innovation that improves outcomes and save lives.
Learn more at www.lumavision.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/luma-vision-to-showcase-verafeye-4d-imaging-platform-at-hrs-2026-signaling-a-new-foundation-for-ep-guidance-302747954.html
SOURCE LUMA Vision
Technology
Blaize and Datacomm Sign Technology Alliance MOU to Explore AI Inference Solutions Across Indonesia
Published
15 minutes agoon
April 21, 2026By
Technology Alliance Targets Indonesia’s Growing AI Inference Market, with an Initial Focus on Physical AI, Public Safety, Surveillance, and Industrial AI Applications
EL DORADO HILLS, Calif. and JAKARTA, Indonesia, April 21, 2026 /PRNewswire/ — Blaize Holdings, Inc. (Nasdaq: BZAI, Nasdaq: BZAIW) (“Blaize,” the “Company,” “we,” “our,” or “us”), a global leader in programmable, energy efficient AI computing, and PT Datacomm Diangraha (“Datacomm”), one of Indonesia’s leading IT service providers and cloud infrastructure specialists, today announced the signing of a Memorandum of Understanding (MOU) establishing a technology alliance to explore the potential of AI inference solutions across Indonesia.
The MOU was signed during a ceremony at Gitex Asia 2026 in Singapore, marking a meaningful step in both companies’ shared commitment to advancing practical AI capabilities across the Indonesian market.
Indonesia: A Strategic AI Market
Indonesia is one of the fastest-growing AI markets in Asia Pacific, with global hyperscalers, sovereign infrastructure programs, and enterprise technology providers all accelerating their presence in the country. According to the Empowering Indonesia Report 2025 by Indosat Ooredoo Hutchison and research firm Twimbit, sovereign AI could contribute up to USD $140 billion to Indonesia’s GDP by 2030, driving annual economic growth of up to 6.8%. Indonesia’s AI sector is expanding at a 31% CAGR, the fastest rate in Southeast Asia (Marketing-Interactive, 2026). Blaize and Datacomm are positioning this technology alliance to serve that growing demand, with an initial focus on physical AI, public safety, surveillance, industrial AI, and logistics.
Areas of Exploration
Under the MOU, Blaize and Datacomm intend to explore the following areas of cooperation:
AI Inference as a Service on DCloud: Exploring integration of Blaize’s Hybrid AI platform with Datacomm’s DCloud public cloud platform and datacenter infrastructure to enable scalable inference services for enterprise customers across Indonesia.Physical AI, Public Safety, Surveillance, and Logistics: Exploring AI inference use cases spanning physical security, video analytics, smart surveillance, and logistics optimization across Indonesia’s enterprise and public sector.Industrial AI: Jointly exploring AI inference applications for industrial automation, including computer vision and sensor-driven intelligence for Indonesia’s industrial sector.
“Asia Pacific is at an inflection point for AI inference, and Indonesia stands out as one of the region’s most significant contributors to that growth,” said Dinakar Munagala, Co-Founder and Chief Executive Officer of Blaize. “Datacomm brings exactly the trusted, deeply embedded infrastructure presence and enterprise relationships this market requires. Together, we are exploring how Blaize’s programmable, energy-efficient AI platform can unlock real-world value across public safety, smart infrastructure, physical AI, and logistics throughout Indonesia. This alliance is a strong foundation, and we intend to build on it.”
“At Datacomm, we have spent over three decades earning the trust of Indonesia’s enterprises, government institutions, and critical infrastructure operators,” said Tan Wie Tjin, President Director and Founder of PT Datacomm Diangraha. “Indonesia is on the cusp of a significant AI transformation, and the demand for intelligent, scalable, and secure inference solutions is accelerating across every sector we serve. This alliance with Blaize is a natural and exciting step in our journey toward the AI era. The combination of Datacomm’s cloud and datacenter infrastructure with Blaize’s world-class AI inference platform positions us uniquely to serve this demand. I look forward to exploring the possibilities this technology alliance will unlock for our customers and for Indonesia’s digital future.”
The MOU is non-binding and outlines a cooperative technology framework under which the parties may pursue specific projects through future definitive agreements. The alliance will prioritize enabling secure, scalable, and energy-efficient AI inference solutions that integrate seamlessly into existing cloud, datacenter, and physical environments across Indonesia.
About Blaize
Blaize delivers a programmable AI platform, purpose-built for AI inference workloads in real-world environments. Its Hybrid AI architecture combines the Blaize GSP (Graph Streaming Processor), an efficient AI processor, with GPU-based infrastructure, enabling AI inference workloads to run across edge, cloud, and data center. Blaize solutions support computer vision, multimodal AI, and sensor-driven applications across smart cities, industrial automation, telecommunications, retail, logistics, and defense. Blaize is headquartered in El Dorado Hills, California, with a global presence across North America, Europe, the Middle East, and Asia. To learn more, visit www.blaize.com or follow us on LinkedIn @blaizeinc.
About Datacomm
PT Datacomm Diangraha is one of Indonesia’s leading IT service providers, with over 30 years of experience in building and managing critical digital infrastructure. Founded in 1990 and headquartered in South Jakarta, Datacomm has grown from a data communication reseller into a comprehensive technology services company with more than 450 employees. The company serves customers across the enterprise, telecommunications, government, and military sectors through an end-to-end IT ecosystem that supports business transformation, covering cloud services, modern data center solutions, advanced IT security, DevOps, and reliable network infrastructure.
For more information, visit www.datacomm.co.id
Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the U.S. Securities Exchange Act of 1934, as amended (the “Exchange Act”) that are based on beliefs and assumptions and on information currently available to Blaize, including statements regarding the expected scope of the engagement with Datacomm and any potential definitive agreements related thereto; the industry in which Blaize operates, market opportunities, and product offerings. In some cases, you can identify forward-looking statements by the following words: “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing,” “target,” “seek” or the negative or plural of these words, or other similar expressions that are predictions or indicate future events or prospects, although not all forward-looking statements contain these words. Forward-looking statements are predictions, projections, and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this document, including but not limited to: (i) changes in domestic and foreign business, market, financial, political and legal conditions; (ii) failure to realize the anticipated benefits of Blaize’s business combination with BurTech Acquisition Corp., which may be affected by, among other things, competition, the ability of the combined company to grow and manage growth profitably, maintain relationships with customers and suppliers and retain its management and key employees; and (iii) those factors discussed under the heading “Risk Factors” in our Annual Report on Form 10-K filed with the Securities and Exchange Commission (SEC) on March 24, 2026, our and other documents filed by Blaize from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and Blaize assumes no obligation to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law, including the securities laws of the United States and the rules and regulations of the SEC. Blaize does not give any assurance that it will achieve its expectations.
Blaize Contact
press@blaize.com
www.blaize.com
Investors
ir@blaize.com
www.blaize.com
View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/blaize-and-datacomm-sign-technology-alliance-mou-to-explore-ai-inference-solutions-across-indonesia-302748491.html
SOURCE Blaize Inc.
Portland Public Library Delivers Almost 50% Increase In User Engagement with New Web Redesign
LUMA Vision to Showcase VERAFEYE 4D Imaging Platform at HRS 2026, Signaling a New Foundation for EP Guidance
Blaize and Datacomm Sign Technology Alliance MOU to Explore AI Inference Solutions Across Indonesia
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
Send Rakhi to UK swiftly with UK Gifts Portal
New Gooseneck Omni Antennas Offer Enhanced Signals in a Durable Package
Why You Should Build on #NEAR – Co-founder Illia Polosukhin at CV Labs
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
NEAR End of Year Town Hall 2021: The Open Web World, MetaBUILD 2 Hackathon and 2021 recap
Trending
-
Technology4 days agoInterfaith America Works to Promote Free, Fair and Peaceful Elections
-
Coin Market4 days agoFrench finance minister backs euro-pegged stablecoins to compete with US
-
Technology2 days agoHarmonic Enables DIRECTV to Reimagine Nationwide DTH Service
-
Near Videos4 days agoWe Have Only Scratched The Surface Of The Agentic Future
-
Coin Market4 days agoSingapore Gulf Bank adds stablecoin mint and redeem for 24/7 settlement
-
Near Videos4 days agoAnthropic Cuts Off OpenClaw Subscribers | GPT-Image-2 Leaked | Drift $285M Hack Explained
-
Technology4 days agoDynamite Integrates Biometric Cryptography and AI into its Wallet Product
-
Coin Market3 days agoBitcoin mining difficulty falls, but projected to rise in next adjustment
